We also evaluated the effect of COL11A1 on endocrine therapeutic responses of breast cancer patients by ROC plotter server, and demonstrated that COL11A1 expression was significantly elevated in the non-responder group compared to the responder group (Fig. 1e). This evidence concerns the gene COL11A1 and breast cancer.